This stock could be a surprise growth pick for 2021 – Motley Fool
This stock could be a surprise growth pick for 2021 – Motley Fool
Many people have written off Amarin (NASDAQ: AMRN) for dead. The stock sells for a little over three times the earnings and three times the money than the books. Biotechnology has only one drug, Vascepa. It is an amazing drug that reduces strokes and heart attacks in statin patients. Harvard professor of medicine Dr. Deepak […]
The post This stock could be a surprise growth pick for 2021 – Motley…
Discover more from USNewsRank
Subscribe to get the latest posts sent to your email.